GnRH agonist leuprolide acetate does not confer any protection against ovarian damage induced by chemotherapy and radiationin vitro-Reference-Cited by-同舟云学术

GnRH agonist leuprolide acetate does not confer any protection against ovarian damage induced by chemotherapy and radiationin vitro

Published:2015-10-13 Issue: Volume: Page:dev257
ISSN:0268-1161
Container-title:Human Reproduction
language:en
Short-container-title:Hum. Reprod.

Author:

Bildik Gamze,Akin Nazlı,Senbabaoglu Filiz,Sahin Gizem Nur,Karahuseyinoglu Sercin,Ince Umit,Taskiran Cagatay,Selek Ugur,Yakin Kayhan,Guzel Yilmaz,Ayhan Cem,Alper Ebru,Cetiner Mustafa,Balaban Basak,Mandel Nil Molinas,Esen Tarık,Iwase Akira,Urman Bulent,Oktem Ozgur

Funder

School of

Medicine and the Graduate School of Health Sciences of Koc University

American Hospital Women's Health Center, Comprehensive Cancer Care and Fertility Preservation Programs

Publisher

Oxford University Press (OUP)

Subject

Obstetrics and Gynecology,Rehabilitation,Reproductive Medicine

Link

http://academic.oup.com/humrep/article-pdf/30/12/2912/17372544/dev257.pdf

Reference36 articles.

1. The effects of paclitaxel, dose density, and trastuzumab on treatment-related amenorrhea in premenopausal women with breast cancer